CA125 is a well-known tumor marker of ovarian cancer, and rates of CA125 positivity detected in ovarian cancer and primary breast cancer specimens by immunohistochemistry were 90% (38/42) (strong and diffuse staining) and 16% (6/36) (focal and weak staining), respectively [13]. The gene discussed is MUC16; the disease is ovarian cancer.